CALYX VENTURES INC. ("CYX")
[formerly Calyx Bio-Ventures Inc. ("CYX")]
BULLETIN TYPE: Name Change
BULLETIN DATE: February 1, 2018
TSX Venture Tier 2 Company
Pursuant to a resolution passed by the Directors dated November 27, 2017, the Company has changed its name as follows. There is no consolidation of capital.
Effective at the opening on February 5, 2018, the common shares of Calyx Ventures Inc. will commence trading on TSX Venture Exchange, and the common shares of Calyx Bio-Ventures Inc. will be delisted. The Company is classified as a 'Research and Development' company.
Capitalization: Unlimited shares with no par value of which
66,424,529 shares are issued and outstanding
Escrow: Nil
Transfer Agent: Computershare Investor Services Inc.
Trading Symbol: CYX (unchanged)
CUSIP Number: 13173G108 (new)
________________________________________
|
|
